Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.

Tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor-binding protein-7 (IGFBP7) are both involved in renal tubular epithelial cell cycle arrest in acute kidney injury (AKI). Several recent studies showed that urine TIMP-2 times IGFBP7 ([TIMP-2]*[IGFBP7]) is a promising bio...

Full description

Bibliographic Details
Main Authors: Yuanyuan Su, Zhiyan Gong, Yan Wu, Yuan Tian, Xiaohui Liao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5249150?pdf=render
_version_ 1798043156863778816
author Yuanyuan Su
Zhiyan Gong
Yan Wu
Yuan Tian
Xiaohui Liao
author_facet Yuanyuan Su
Zhiyan Gong
Yan Wu
Yuan Tian
Xiaohui Liao
author_sort Yuanyuan Su
collection DOAJ
description Tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor-binding protein-7 (IGFBP7) are both involved in renal tubular epithelial cell cycle arrest in acute kidney injury (AKI). Several recent studies showed that urine TIMP-2 times IGFBP7 ([TIMP-2]*[IGFBP7]) is a promising biomarker to predict AKI.The aim of this meta-analysis was to assess the diagnostic value of urine [TIMP-2]*[IGFBP7] for early diagnosis of AKI. Relevant studies were retrieved from the PubMed, EMBASE, and Cochrane Library databases. The sensitivity and specificity were determined, and summary receiver operating characteristic (SROC) curves were constructed.Ten full-text prospective studies were included in this meta-analysis. The estimated sensitivity of urine [TIMP-2]*[IGFBP7] for the early diagnosis of AKI was 0.84 (95% CI = 0.80-0.88) and the specificity was 0.57 (95%CI = 0.55-0.60). The SROC analysis showed an area under the curve of 0.8813.The limited number of included studies, small sample size, unpublished negative results and language limitation might have affected the evaluation.Urine [TIMP-2]*[IGFBP7] is a promising candidate for early detection of AKI, especially in ruling-out AKI. However, the potential of this biomarker should be validated in larger studies with a broader spectrum of clinical settings.
first_indexed 2024-04-11T22:45:39Z
format Article
id doaj.art-bae2d09fe78e48a59862f0a56cfe5c1c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T22:45:39Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-bae2d09fe78e48a59862f0a56cfe5c1c2022-12-22T03:58:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01121e017021410.1371/journal.pone.0170214Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.Yuanyuan SuZhiyan GongYan WuYuan TianXiaohui LiaoTissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor-binding protein-7 (IGFBP7) are both involved in renal tubular epithelial cell cycle arrest in acute kidney injury (AKI). Several recent studies showed that urine TIMP-2 times IGFBP7 ([TIMP-2]*[IGFBP7]) is a promising biomarker to predict AKI.The aim of this meta-analysis was to assess the diagnostic value of urine [TIMP-2]*[IGFBP7] for early diagnosis of AKI. Relevant studies were retrieved from the PubMed, EMBASE, and Cochrane Library databases. The sensitivity and specificity were determined, and summary receiver operating characteristic (SROC) curves were constructed.Ten full-text prospective studies were included in this meta-analysis. The estimated sensitivity of urine [TIMP-2]*[IGFBP7] for the early diagnosis of AKI was 0.84 (95% CI = 0.80-0.88) and the specificity was 0.57 (95%CI = 0.55-0.60). The SROC analysis showed an area under the curve of 0.8813.The limited number of included studies, small sample size, unpublished negative results and language limitation might have affected the evaluation.Urine [TIMP-2]*[IGFBP7] is a promising candidate for early detection of AKI, especially in ruling-out AKI. However, the potential of this biomarker should be validated in larger studies with a broader spectrum of clinical settings.http://europepmc.org/articles/PMC5249150?pdf=render
spellingShingle Yuanyuan Su
Zhiyan Gong
Yan Wu
Yuan Tian
Xiaohui Liao
Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.
PLoS ONE
title Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.
title_full Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.
title_fullStr Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.
title_full_unstemmed Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.
title_short Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.
title_sort diagnostic value of urine tissue inhibitor of metalloproteinase 2 and insulin like growth factor binding protein 7 for acute kidney injury a meta analysis
url http://europepmc.org/articles/PMC5249150?pdf=render
work_keys_str_mv AT yuanyuansu diagnosticvalueofurinetissueinhibitorofmetalloproteinase2andinsulinlikegrowthfactorbindingprotein7foracutekidneyinjuryametaanalysis
AT zhiyangong diagnosticvalueofurinetissueinhibitorofmetalloproteinase2andinsulinlikegrowthfactorbindingprotein7foracutekidneyinjuryametaanalysis
AT yanwu diagnosticvalueofurinetissueinhibitorofmetalloproteinase2andinsulinlikegrowthfactorbindingprotein7foracutekidneyinjuryametaanalysis
AT yuantian diagnosticvalueofurinetissueinhibitorofmetalloproteinase2andinsulinlikegrowthfactorbindingprotein7foracutekidneyinjuryametaanalysis
AT xiaohuiliao diagnosticvalueofurinetissueinhibitorofmetalloproteinase2andinsulinlikegrowthfactorbindingprotein7foracutekidneyinjuryametaanalysis